About SCS

At Skin Cancer Scanning Ltd. (SCS) we want to improve quality of life for millions of people around the world with our revolutionary, non-invasive, painless technology that can be completed quickly in the doctor’s office to diagnose skin cancer at an earlier, more curable stage.

We believe SkinScan 650 will enable physicians to diagnose skin cancer at an earlier, most curable stage with fewer false positive biopsies. This would reduce both treatment costs and the number of unnecessary biopsies, and improve quality of life.

Read more…

Skinscan 650

Our system, SkinScan 650, replaces current diagnostic procedures that have many disadvantages such as being relatively subjective and too dependent on the experience of the examiner. These errors in diagnosis can be fatal. Cancers can remain undetected, grow further and reduce to chances of survival. A biopsy, the intrusive removal of tissue sample, is usually needed for further diagnoses.

Reducing the need for biopsies means less scarring, less pain, and perhaps most importantly, less patient anxiety from the time lag between the examination and the biopsy results.
Read more…


Professor Nathan Blaunstein , MSc, DSc, PhD., Professor Blaunstein is a world-recognized expert in radio-physics and electronics, and has authored more than ten books as well as over 150 articles in scientific journals and conference papers. Professor Blaunstein is a member of the New York Academy of Science since 1997. Professor Blaunstein has received many prestigious scientific awards, including the Leonardo Da’Vinci Prize as one of 2000 outstanding Intellectual of the 21st Century,  awarded   by the international biographical center Cambridge.  Read more

view award certificate



President conference

Skin Cancer Scanning Ltd. (SCS) is a medical device company focused on developing and marketing a non-invasive, painless skin cancer diagnosing test that can be completed quickly in the doctor’s office. Our new way of diagnosing skin cancer improves early detection and more accurate diagnose of skin cancer and detect and diagnose melanoma, non-melanoma, and skin lesions.